<?xml version="1.0" ?>
<tei>
	<teiHeader>
		<fileDesc xml:id="55009625"/>
	</teiHeader>
	<text xml:lang="en">
		<front>
<lb/>
	<note type="other">TEMPLATE DESIGN</note>

	<note type="copyright">Â© 2008<lb/></note>

	<ptr>www.PosterPresentations.com<lb/></ptr>

	<docTitle>
	<titlePart>A phase I, pharmacokinetic (PK) and preliminary efficacy assessment of ALD518, a humanized anti-IL-6 antibody, in<lb/> patients with advanced cancer.<lb/></titlePart>
	</docTitle>

	<byline>
	<docAuthor>S Clarke 1 , C. Gebbie 1 , C Sweeney 2 , N Olszewksi 2 , J Smith 3<lb/></docAuthor>
	</byline>

	<byline>
	<affiliation>1 Sydney Cancer Centre, Concord Hospital,</affiliation>
	</byline>

	<address>Sydney, Australia;</address>

	<byline>
	<affiliation>2 University of Adelaide, Royal Adelaide Hospital,</affiliation>
	</byline>

	<address>Adelaide, Australia;</address>

	<byline>
	<affiliation>3 Alder Biopharmaceuticals Inc,</affiliation>
	</byline>

	<address>Bothell, WA, USA<lb/></address>

		</front>
	</text>
</tei>
